Recurrent intracranial esthesioneuroblastoma outside the initial field of radiation with progressive dural and intra-orbital invasion

Acta Neurochirurgica

Volumn 146, Issue 2, 2004, Pages 179-182

  Tamase, A ^a   Nakada, M ^a   Hasegawa, Mitsuhiro ^a   Shima, H ^a   Yamashita, J ^a   Hausamen, J E ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

Intracranial esthesioneuroblastoma; Optimal radiotherapy; Recurrence

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; DURA MATER; ESTHESIONEUROBLASTOMA; HUMAN; HUMAN TISSUE; MALE; MINIMAL RESIDUAL DISEASE; NEUROIMAGING; ORBIT; POSTOPERATIVE CARE; PRIORITY JOURNAL; TUMOR LOCALIZATION; TUMOR VOLUME;

BRAIN NEOPLASMS; CELL DIVISION; COMBINED MODALITY THERAPY; CRANIAL FOSSA, ANTERIOR; CRANIAL FOSSA, MIDDLE; CRANIAL IRRADIATION; DOSE FRACTIONATION; DURA MATER; ESTHESIONEUROBLASTOMA, OLFACTORY; FOLLOW-UP STUDIES; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; ORBITAL NEOPLASMS; PARANASAL SINUS NEOPLASMS; RADIOTHERAPY, ADJUVANT; REOPERATION; SKULL BASE NEOPLASMS; TEMPORAL LOBE;

EID: 1542380879     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00701-003-0179-y     Document Type: Article

References (17)

1. Spiro JD, Soo KC, Spiro RH (1995) Nonsquamous cell malignant neoplasms of the nasal cavities and paranasal sinuses. Head Neck 17: 114-118
2. O'Connor TA, McLean P, Juillard GJ, Parker RG (1989) Olfactory neuroblastoma. Cancer 63: 2426-2428
3. Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM (1993) Esthesioneuroblastoma: prognosis and management. Neurosurgery 32: 706-714
4. Meneses MS, Thurel C, Mikol J, Ramina R, Maniglia JJ, Arruda WO, Cophignon J (1990) Esthesioneuroblastoma with intracranial extension. Neurosurgery 27: 813-819
5. Eich HT, Staar S, Micke O, Eich PD, Stutzer H, Muller R (2001) Radiotherapy of esthesioneuroblastoma. Int J Radiat Oncol Biol Phys 49: 155-160
6. Urdaneta N, Fischer JJ, Knowlton A (1988) Olfactory neuroblastoma. Observations on seven patients treated with radiation therapy and review of the literature. Am J Clin Oncol 11: 672-678
7. Broich G, Pagliari A, Ottaviani F (1997) Esthesioneuroblastoma: general review of the cases published since the discovery of the tumour in 1924. Anticancer Res 17: 2683-2706
8. Dulguerov P, Calcaterra T (1992) Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 102: 843-849
9. Zappia JJ, Carroll WR, Wolf GT, Thornton AF, Ho L, Krause CJ (1993) Olfactory neuroblastoma: the results of modern treatment approaches at the University of Michigan. Head Neck 15: 190-196
10. Dulguerov P, Allal AS, Calcaterra TC (2001) Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2: 683-690
11. McElroy EA Jr, Buckner JC, Lewis JE (1998) Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. Neurosurgery 42: 1023-1027
12. Resto VA, Eisele DW, Forastiere A, Zahurak M, Lee DJ, Westra WH (2000) Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck 22: 550-558
13. Tatagiba M, Samii M, Dankoweit-Timpe E, Aguiar PH, Osterwald L, Babu R, Ostertag H (1995) Esthesioneuroblastomas with intracranial extension. Proliferative potential and management. Arq Neuropsiquiatr 53: 577-586
14. Kadish S, Goodman M, Wang CC (1976) Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 37: 1571-1576
15. Sheline GE, Wara WM, Smith V (1980) Therapeutic irradiation and brain injury, Int J Radiat Oncol Biol Phys 6: 1215-1228
16. Zabel A, Thilmann C, Milker-Zabel S, Schlegel W, Zuna I, Wannenmacher M, Debus J (2002) The role of stereotactically guided conformal radiotherapy for local tumor control of esthesioneuroblastoma. Strahlenther Onkol 178: 187-191
17. Walch C, Stammberger H, Anderhuber W, Unger F, Kole W, Feichtinger K (2000) The minimally invasive approach to olfactory neuroblastoma: combined endoscopic and stereotactic treatment. Laryngoscope 110: 635-640